Development and Clinical Application of a Chemiluminescence Immunoassay for Determination of Carbohydrate Antigen 125
Abstract: To develop a chemiluminescence immunoassay (CLIA) kit for quantitative determination of tumor marker carbohydrate antigen 125 (CA125) and evaluate its value of clinical application, CLIA for quantitative determination of CA125 was established by using micro-plates coated with antibody to CA125, combined with HRP conjugated anti-CA125 antibody, as well as luminol chemiluminescence substrate system. The national reference control sera were used for evaluation of specificity, sensitivity, stability and accuracy of the established CLIA. CA125 levels in sera from 350 clinical samples were parallel determined by the established methods and reference kits produced by the Siemens. The results show that the efficiency of the CLIA reagents met the requirements of national reference standard. The intra coefficient variations (CV) were between 2.8%~3.6% and inter CV 3.7%. The kit showed good stability after being kept at 37˚C for 3d. The established CLIA showed good correlation with the reference kits (negative concordance rate, positive concordance rate and overall concordance rate were 99.5%, 99.3% and 99.4% respectively, and a correlation coefficient r = 0.9897. High degree of agreement was observed with a Kappa value of 0.99). A rapid, specific, sensitive and stable CLIA kit for quantitative determina-tion of CA125 was successfully established and that will be fit for widely application in clinical laboratory.
文章引用: 戴志文 , 戴振贤 , 张剑清 , 谢玉玲 , 薛正翔 , 吴玉水 (2016) 糖类抗原125化学发光免疫定量检测试剂的研制与临床应用。 免疫学研究， 4， 9-14. doi: 10.12677/IS.2016.42002
 汪晨, 吴洁, 宗晨, 等. 化学发光免疫分析方法与应用进展[J]. 分析化学, 2012, 40(1): 3-10.
 Holschneider, C.H. and Berek, J.S. (2000) Ovarian Cancer: Epidemiology, Biology, and Prognostic Factors. Seminars in Surgical Oncology, 19, 3-10．http://dx.doi.org/10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S
 王莉, 李娜, 吴小华, 等. 间皮素和CA125在卵巢上皮性肿瘤中的共定位表达及临床意义[J]. 肿瘤, 2009, 29(4): 358-560.
 胡元晶, 李娜, 曲芃芃, 等. 晚期卵巢癌化疗中CA125下降的临床意义[J].中国肿瘤临床, 2010, 37(18): 1062- 1063.
 Meyer, T. and Rustin, G.J. (2000) Role of Tumour Markers in Monitoring Epithelial Ovarian Cancer. British Journal of Cancer, 82, 1535-1538．
 黄伟, 项杰. CA125在肺部疾病鉴别诊断中的应用[J]. 临床和实验医学杂志, 2012, 11(6): 444-445.